An AllTrials project

NCT06326060: An ongoing trial by Novo Nordisk A/S

This trial is ongoing. It must report results 3 months, 3 weeks from now.

Full data

Full entry on ClinicalTrials.gov NCT06326060
Title Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study
Results Status Ongoing
ACT or pACT? This is what FDAAA officially calls an "Applicable Clinical Trial"
Start date March 18, 2024
Completion date April 10, 2025
Required reporting date April 10, 2026, midnight
Actual reporting date None
Date last checked at ClinicalTrials.gov Dec. 12, 2025
Days late None